Li, Lingjun
Cai, Baole
Li, Hongyang
Wei, Jun
Tao, Lei
Ma, Pengcheng
Funding for this research was provided by:
The funding source of the work was supported by Nanjing Changao Pharmaceutical Co. Ltd.
Article History
Received: 6 March 2023
Accepted: 19 September 2023
First Online: 12 October 2023
Declarations
:
: The study was approved by the Ethics Committee of the Hospital of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College (Nanjing, China) (ethics approval number: 2021-LC-001), according to the Declaration of Helsinki.
: All volunteers provided written informed consent forms before participation in the study and after having been fully informed about the aim, course, and possible risks of the study.
: Not applicable.
: The authors declare no competing interests.